Advancements in technology and a deeper understanding of cancer biology continue to refine molecular classification. Emerging fields like liquid biopsy and single-cell sequencing offer new avenues for more accurate and less invasive classification. The integration of multi-omics data will further enhance our ability to classify tumors and personalize cancer treatment.
